nodes	percent_of_prediction	percent_of_DWPC	metapath
Desoximetasone—Dermatitis acneiform—Erlotinib—lung cancer	0.0457	0.0686	CcSEcCtD
Desoximetasone—Burning sensation—Crizotinib—lung cancer	0.0414	0.0621	CcSEcCtD
Desoximetasone—Acne—Gefitinib—lung cancer	0.0311	0.0466	CcSEcCtD
Desoximetasone—Pigmentation disorder—Etoposide—lung cancer	0.0278	0.0416	CcSEcCtD
Desoximetasone—Pigmentation disorder—Paclitaxel—lung cancer	0.0272	0.0408	CcSEcCtD
Desoximetasone—Folliculitis—Erlotinib—lung cancer	0.0249	0.0373	CcSEcCtD
Desoximetasone—Amcinonide—ANXA1—lung cancer	0.0246	0.306	CrCbGaD
Desoximetasone—Telangiectasia—Methotrexate—lung cancer	0.0236	0.0353	CcSEcCtD
Desoximetasone—Acne—Erlotinib—lung cancer	0.0186	0.0278	CcSEcCtD
Desoximetasone—NR3C1—Endoderm Differentiation—BPTF—lung cancer	0.0174	0.069	CbGpPWpGaD
Desoximetasone—Secondary infection—Doxorubicin—lung cancer	0.0164	0.0245	CcSEcCtD
Desoximetasone—Folliculitis—Paclitaxel—lung cancer	0.0145	0.0217	CcSEcCtD
Desoximetasone—Pigmentation disorder—Doxorubicin—lung cancer	0.0144	0.0216	CcSEcCtD
Desoximetasone—Leukoderma—Methotrexate—lung cancer	0.0131	0.0196	CcSEcCtD
Desoximetasone—Erythema—Pemetrexed—lung cancer	0.0115	0.0172	CcSEcCtD
Desoximetasone—Leukoderma—Doxorubicin—lung cancer	0.0113	0.0169	CcSEcCtD
Desoximetasone—Burning sensation—Docetaxel—lung cancer	0.0111	0.0166	CcSEcCtD
Desoximetasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—lung cancer	0.0107	0.0426	CbGpPWpGaD
Desoximetasone—Hydrocortisone—ANXA1—lung cancer	0.0103	0.129	CrCbGaD
Desoximetasone—Infection—Crizotinib—lung cancer	0.0102	0.0153	CcSEcCtD
Desoximetasone—Infection—Pemetrexed—lung cancer	0.00932	0.014	CcSEcCtD
Desoximetasone—Infection—Gefitinib—lung cancer	0.00927	0.0139	CcSEcCtD
Desoximetasone—Folliculitis—Methotrexate—lung cancer	0.00883	0.0132	CcSEcCtD
Desoximetasone—Psoriasis—Methotrexate—lung cancer	0.00883	0.0132	CcSEcCtD
Desoximetasone—Pain—Pemetrexed—lung cancer	0.00803	0.012	CcSEcCtD
Desoximetasone—Burning sensation—Methotrexate—lung cancer	0.00799	0.012	CcSEcCtD
Desoximetasone—NR3C1—Nuclear Receptors—RARB—lung cancer	0.00799	0.0317	CbGpPWpGaD
Desoximetasone—Pain—Gefitinib—lung cancer	0.00798	0.012	CcSEcCtD
Desoximetasone—Dexamethasone—ANXA1—lung cancer	0.00771	0.096	CrCbGaD
Desoximetasone—Folliculitis—Doxorubicin—lung cancer	0.00765	0.0115	CcSEcCtD
Desoximetasone—Psoriasis—Doxorubicin—lung cancer	0.00765	0.0115	CcSEcCtD
Desoximetasone—NR3C1—Endoderm Differentiation—NKX2-1—lung cancer	0.00759	0.0301	CbGpPWpGaD
Desoximetasone—Infection—Teniposide—lung cancer	0.00755	0.0113	CcSEcCtD
Desoximetasone—Burning sensation—Doxorubicin—lung cancer	0.00692	0.0104	CcSEcCtD
Desoximetasone—Erythema—Erlotinib—lung cancer	0.00683	0.0102	CcSEcCtD
Desoximetasone—Pruritus—Pemetrexed—lung cancer	0.00664	0.00995	CcSEcCtD
Desoximetasone—Pruritus—Gefitinib—lung cancer	0.0066	0.00989	CcSEcCtD
Desoximetasone—Dermatitis—Crizotinib—lung cancer	0.00647	0.0097	CcSEcCtD
Desoximetasone—NR3C1—Endoderm Differentiation—NODAL—lung cancer	0.00645	0.0256	CbGpPWpGaD
Desoximetasone—NR3C1—Nuclear Receptor transcription pathway—RARB—lung cancer	0.00631	0.025	CbGpPWpGaD
Desoximetasone—Hyperglycaemia—Gemcitabine—lung cancer	0.00614	0.00921	CcSEcCtD
Desoximetasone—Glycosuria—Doxorubicin—lung cancer	0.00593	0.00889	CcSEcCtD
Desoximetasone—Stinging—Doxorubicin—lung cancer	0.00593	0.00889	CcSEcCtD
Desoximetasone—Dermatitis—Pemetrexed—lung cancer	0.00591	0.00886	CcSEcCtD
Desoximetasone—Erythema—Vinorelbine—lung cancer	0.00591	0.00885	CcSEcCtD
Desoximetasone—Dermatitis—Gefitinib—lung cancer	0.00587	0.0088	CcSEcCtD
Desoximetasone—Infection—Topotecan—lung cancer	0.0056	0.00839	CcSEcCtD
Desoximetasone—Infection—Erlotinib—lung cancer	0.00554	0.0083	CcSEcCtD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SKI—lung cancer	0.00543	0.0215	CbGpPWpGaD
Desoximetasone—Pruritus—Teniposide—lung cancer	0.00538	0.00806	CcSEcCtD
Desoximetasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—lung cancer	0.00524	0.0208	CbGpPWpGaD
Desoximetasone—Hyperglycaemia—Paclitaxel—lung cancer	0.00514	0.00771	CcSEcCtD
Desoximetasone—Pain—Vinblastine—lung cancer	0.00496	0.00743	CcSEcCtD
Desoximetasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—lung cancer	0.00494	0.0196	CbGpPWpGaD
Desoximetasone—NR3C1—Endoderm Differentiation—SOX2—lung cancer	0.00489	0.0194	CbGpPWpGaD
Desoximetasone—Pain—Topotecan—lung cancer	0.00482	0.00722	CcSEcCtD
Desoximetasone—Dermatitis—Teniposide—lung cancer	0.00479	0.00718	CcSEcCtD
Desoximetasone—Infection—Vinorelbine—lung cancer	0.00479	0.00718	CcSEcCtD
Desoximetasone—NR3C1—AP-1 transcription factor network—NPPA—lung cancer	0.00478	0.0189	CbGpPWpGaD
Desoximetasone—Pain—Erlotinib—lung cancer	0.00477	0.00715	CcSEcCtD
Desoximetasone—Dermatitis contact—Doxorubicin—lung cancer	0.00475	0.00712	CcSEcCtD
Desoximetasone—Erythema—Gemcitabine—lung cancer	0.00475	0.00711	CcSEcCtD
Desoximetasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—lung cancer	0.00469	0.0186	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—ATF3—lung cancer	0.00452	0.0179	CbGpPWpGaD
Desoximetasone—Clobetasol propionate—CYP1A1—lung cancer	0.00443	0.0551	CrCbGaD
Desoximetasone—Erythema—Cisplatin—lung cancer	0.00442	0.00663	CcSEcCtD
Desoximetasone—NR3C1—Endoderm Differentiation—PTHLH—lung cancer	0.00416	0.0165	CbGpPWpGaD
Desoximetasone—Prednisolone—CYP2A6—lung cancer	0.00415	0.0517	CrCbGaD
Desoximetasone—Pain—Vinorelbine—lung cancer	0.00412	0.00618	CcSEcCtD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—SFN—lung cancer	0.00408	0.0161	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—lung cancer	0.00402	0.0159	CbGpPWpGaD
Desoximetasone—Pruritus—Topotecan—lung cancer	0.00399	0.00598	CcSEcCtD
Desoximetasone—Erythema—Paclitaxel—lung cancer	0.00397	0.00595	CcSEcCtD
Desoximetasone—Infection—Irinotecan—lung cancer	0.00395	0.00592	CcSEcCtD
Desoximetasone—Pruritus—Erlotinib—lung cancer	0.00394	0.00591	CcSEcCtD
Desoximetasone—Infection—Gemcitabine—lung cancer	0.00385	0.00577	CcSEcCtD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—lung cancer	0.00375	0.0149	CbGpPWpGaD
Desoximetasone—NR3C1—Endoderm Differentiation—APP—lung cancer	0.0037	0.0147	CbGpPWpGaD
Desoximetasone—Infection—Cisplatin—lung cancer	0.00359	0.00537	CcSEcCtD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—CHRNB4—lung cancer	0.00357	0.0141	CbGpPWpGaD
Desoximetasone—Dermatitis—Topotecan—lung cancer	0.00355	0.00532	CcSEcCtD
Desoximetasone—Dermatitis—Erlotinib—lung cancer	0.00351	0.00526	CcSEcCtD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—IRF1—lung cancer	0.0035	0.0139	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—JUNB—lung cancer	0.00343	0.0136	CbGpPWpGaD
Desoximetasone—NR3C1—Circadian Clock—AVP—lung cancer	0.00341	0.0135	CbGpPWpGaD
Desoximetasone—Pruritus—Vinorelbine—lung cancer	0.00341	0.00511	CcSEcCtD
Desoximetasone—Pain—Irinotecan—lung cancer	0.0034	0.0051	CcSEcCtD
Desoximetasone—Erythema—Docetaxel—lung cancer	0.00337	0.00505	CcSEcCtD
Desoximetasone—Pain—Gemcitabine—lung cancer	0.00331	0.00496	CcSEcCtD
Desoximetasone—Infection—Etoposide—lung cancer	0.00329	0.00492	CcSEcCtD
Desoximetasone—Infection—Paclitaxel—lung cancer	0.00322	0.00483	CcSEcCtD
Desoximetasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—lung cancer	0.00316	0.0125	CbGpPWpGaD
Desoximetasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—lung cancer	0.00312	0.0124	CbGpPWpGaD
Desoximetasone—Pain—Cisplatin—lung cancer	0.00309	0.00463	CcSEcCtD
Desoximetasone—Dermatitis—Vinorelbine—lung cancer	0.00304	0.00455	CcSEcCtD
Desoximetasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—lung cancer	0.00303	0.012	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—AHR—lung cancer	0.00299	0.0118	CbGpPWpGaD
Desoximetasone—Hydrocortisone—ABCG2—lung cancer	0.00284	0.0354	CrCbGaD
Desoximetasone—Pain—Etoposide—lung cancer	0.00283	0.00424	CcSEcCtD
Desoximetasone—Pain—Paclitaxel—lung cancer	0.00277	0.00416	CcSEcCtD
Desoximetasone—Fluticasone furoate—ABCB1—lung cancer	0.00275	0.0342	CrCbGaD
Desoximetasone—Pruritus—Gemcitabine—lung cancer	0.00274	0.00411	CcSEcCtD
Desoximetasone—Infection—Docetaxel—lung cancer	0.00273	0.00409	CcSEcCtD
Desoximetasone—Hyperglycaemia—Doxorubicin—lung cancer	0.00272	0.00408	CcSEcCtD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.00271	0.0107	CbGpPWpGaD
Desoximetasone—NR3C1—Circadian Clock—HIF1A—lung cancer	0.00271	0.0107	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO3—lung cancer	0.00267	0.0106	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—IL10—lung cancer	0.00265	0.0105	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—SOX2—lung cancer	0.00252	0.00997	CbGpPWpGaD
Desoximetasone—Dermatitis—Irinotecan—lung cancer	0.0025	0.00375	CcSEcCtD
Desoximetasone—NR3C1—Adipogenesis—LMNA—lung cancer	0.00247	0.00981	CbGpPWpGaD
Desoximetasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—lung cancer	0.00247	0.0098	CbGpPWpGaD
Desoximetasone—Dermatitis—Gemcitabine—lung cancer	0.00244	0.00366	CcSEcCtD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.00244	0.00965	CbGpPWpGaD
Desoximetasone—Erythema—Methotrexate—lung cancer	0.00243	0.00364	CcSEcCtD
Desoximetasone—Dexamethasone—CYP2A6—lung cancer	0.00237	0.0295	CrCbGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—lung cancer	0.00235	0.00933	CbGpPWpGaD
Desoximetasone—Pain—Docetaxel—lung cancer	0.00235	0.00352	CcSEcCtD
Desoximetasone—Pruritus—Etoposide—lung cancer	0.00234	0.00351	CcSEcCtD
Desoximetasone—Pruritus—Paclitaxel—lung cancer	0.00229	0.00344	CcSEcCtD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—CREBBP—lung cancer	0.00228	0.00902	CbGpPWpGaD
Desoximetasone—Dermatitis—Cisplatin—lung cancer	0.00227	0.00341	CcSEcCtD
Desoximetasone—NR3C1—AP-1 transcription factor network—MMP1—lung cancer	0.00225	0.00892	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—HIF1A—lung cancer	0.00223	0.00884	CbGpPWpGaD
Desoximetasone—NR3C1—Circadian Clock—CREBBP—lung cancer	0.00221	0.00875	CbGpPWpGaD
Desoximetasone—Methylprednisolone—ABCB1—lung cancer	0.00219	0.0273	CrCbGaD
Desoximetasone—Triamcinolone—PTGS2—lung cancer	0.00217	0.0271	CrCbGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—TF—lung cancer	0.00214	0.00847	CbGpPWpGaD
Desoximetasone—Dexamethasone—ABCG2—lung cancer	0.00212	0.0263	CrCbGaD
Desoximetasone—Erythema—Doxorubicin—lung cancer	0.0021	0.00315	CcSEcCtD
Desoximetasone—Dermatitis—Etoposide—lung cancer	0.00208	0.00312	CcSEcCtD
Desoximetasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—lung cancer	0.00207	0.00819	CbGpPWpGaD
Desoximetasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—lung cancer	0.00205	0.00813	CbGpPWpGaD
Desoximetasone—Dermatitis—Paclitaxel—lung cancer	0.00204	0.00306	CcSEcCtD
Desoximetasone—NR3C1—Endoderm Differentiation—APC—lung cancer	0.00201	0.00797	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—lung cancer	0.00198	0.00786	CbGpPWpGaD
Desoximetasone—Infection—Methotrexate—lung cancer	0.00197	0.00295	CcSEcCtD
Desoximetasone—Pruritus—Docetaxel—lung cancer	0.00194	0.00291	CcSEcCtD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—MDM2—lung cancer	0.00193	0.00766	CbGpPWpGaD
Desoximetasone—Betamethasone—PTGS2—lung cancer	0.00178	0.0222	CrCbGaD
Desoximetasone—Prednisone—ALB—lung cancer	0.00176	0.0219	CrCbGaD
Desoximetasone—Dermatitis—Docetaxel—lung cancer	0.00173	0.00259	CcSEcCtD
Desoximetasone—Infection—Doxorubicin—lung cancer	0.0017	0.00255	CcSEcCtD
Desoximetasone—Pain—Methotrexate—lung cancer	0.00169	0.00254	CcSEcCtD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—JUN—lung cancer	0.00168	0.00666	CbGpPWpGaD
Desoximetasone—Dexamethasone—CYP2E1—lung cancer	0.00168	0.0209	CrCbGaD
Desoximetasone—Prednisone—ABCB1—lung cancer	0.00168	0.0209	CrCbGaD
Desoximetasone—Dexamethasone—CYP1A1—lung cancer	0.00166	0.0206	CrCbGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—POMC—lung cancer	0.00165	0.00653	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—lung cancer	0.00162	0.00642	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—lung cancer	0.00161	0.00636	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—CDKN2A—lung cancer	0.0016	0.00632	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—EP300—lung cancer	0.00155	0.00614	CbGpPWpGaD
Desoximetasone—Prednisolone—ABCB1—lung cancer	0.00155	0.0192	CrCbGaD
Desoximetasone—Betamethasone—ABCB1—lung cancer	0.00151	0.0188	CrCbGaD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—SRC—lung cancer	0.00151	0.00597	CbGpPWpGaD
Desoximetasone—NR3C1—Circadian Clock—EP300—lung cancer	0.0015	0.00596	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—AVP—lung cancer	0.00148	0.00587	CbGpPWpGaD
Desoximetasone—Pain—Doxorubicin—lung cancer	0.00147	0.0022	CcSEcCtD
Desoximetasone—NR3C1—AP-1 transcription factor network—CXCL8—lung cancer	0.00145	0.00573	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—HES1—lung cancer	0.0014	0.00555	CbGpPWpGaD
Desoximetasone—Pruritus—Methotrexate—lung cancer	0.0014	0.0021	CcSEcCtD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—IL10—lung cancer	0.00139	0.00552	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—IL2—lung cancer	0.00138	0.00548	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—lung cancer	0.00136	0.0054	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—HIF1A—lung cancer	0.00136	0.00539	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—SKI—lung cancer	0.00136	0.00538	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—CCND1—lung cancer	0.00135	0.00534	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—JUN—lung cancer	0.00135	0.00533	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—MMP9—lung cancer	0.00131	0.00519	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—PTEN—lung cancer	0.0013	0.00516	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—lung cancer	0.00128	0.00505	CbGpPWpGaD
Desoximetasone—Dermatitis—Methotrexate—lung cancer	0.00125	0.00187	CcSEcCtD
Desoximetasone—NR3C1—AP-1 transcription factor network—EP300—lung cancer	0.00124	0.00492	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—lung cancer	0.00122	0.00483	CbGpPWpGaD
Desoximetasone—Pruritus—Doxorubicin—lung cancer	0.00121	0.00182	CcSEcCtD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—lung cancer	0.0012	0.00474	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—JUN—lung cancer	0.00119	0.0047	CbGpPWpGaD
Desoximetasone—Hydrocortisone—ABCB1—lung cancer	0.00118	0.0147	CrCbGaD
Desoximetasone—NR3C1—Gene Expression—EIF2B4—lung cancer	0.00118	0.00466	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.00117	0.00465	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—lung cancer	0.00116	0.0046	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—lung cancer	0.00115	0.00455	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—RB1—lung cancer	0.00111	0.00438	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	0.0011	0.00437	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—lung cancer	0.00109	0.00433	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—RARB—lung cancer	0.00109	0.00432	CbGpPWpGaD
Desoximetasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.00109	0.00431	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—MYC—lung cancer	0.00108	0.00428	CbGpPWpGaD
Desoximetasone—Dermatitis—Doxorubicin—lung cancer	0.00108	0.00162	CcSEcCtD
Desoximetasone—NR3C1—Generic Transcription Pathway—NPPA—lung cancer	0.00106	0.00421	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—HNRNPA2B1—lung cancer	0.00105	0.00415	CbGpPWpGaD
Desoximetasone—Dexamethasone—PTGS2—lung cancer	0.00104	0.0129	CrCbGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—lung cancer	0.00098	0.00388	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	0.000962	0.00381	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000961	0.00381	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.00096	0.0038	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—KHSRP—lung cancer	0.000958	0.0038	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—TP53—lung cancer	0.000888	0.00352	CbGpPWpGaD
Desoximetasone—Dexamethasone—ABCB1—lung cancer	0.000881	0.011	CrCbGaD
Desoximetasone—NR3C1—Gene Expression—EIF2B5—lung cancer	0.000838	0.00332	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—IL6—lung cancer	0.000813	0.00322	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	0.000805	0.00319	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—CDKN1A—lung cancer	0.000795	0.00315	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	0.000782	0.0031	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	0.000763	0.00302	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000762	0.00302	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—DICER1—lung cancer	0.000758	0.003	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.00073	0.00289	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	0.000716	0.00284	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—STAT3—lung cancer	0.000709	0.00281	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	0.000709	0.00281	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	0.000667	0.00264	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	0.000661	0.00262	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—SKI—lung cancer	0.000654	0.00259	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	0.000654	0.00259	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000619	0.00245	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—RARB—lung cancer	0.000525	0.00208	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—NPPA—lung cancer	0.000512	0.00203	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—IL6—lung cancer	0.000495	0.00196	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—HSPB1—lung cancer	0.00044	0.00174	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	0.000428	0.0017	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	0.000405	0.00161	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—NOTCH3—lung cancer	0.000388	0.00154	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—JUNB—lung cancer	0.000367	0.00145	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—ERCC2—lung cancer	0.000267	0.00106	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—MYC—lung cancer	0.000241	0.000953	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—CREBBP—lung cancer	0.000195	0.000773	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—MAPK3—lung cancer	0.000119	0.000472	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—MYC—lung cancer	0.000116	0.000459	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—AKT1—lung cancer	8.03e-05	0.000318	CbGpPWpGaD
